Skip to main content
Log in

Effects of propranolol on conversational reciprocity in autism spectrum disorder: a pilot, double-blind, single-dose psychopharmacological challenge study

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

Pharmacological intervention for autism spectrum disorder (ASD) is an important addition to treatment, yet currently available agents target co-morbid psychiatric concerns, such as aggression and irritability. Propranolol, a beta-adrenergic antagonist with anxiolytic effects, has been shown to improve verbal fluency and working memory in adults and adolescents with ASD in single-dose challenges.

Objectives

The present pilot study explores the acute effects of propranolol on a measure of conversational reciprocity in this population. We also examined whether autonomic activity and anxiety moderate or mediate response to the drug, given relationships between these variables and ASD, as well as the drug’s effects.

Methods

In a within-subject crossover design, 20 individuals with ASD received a single dose of propranolol or placebo during two sessions in a double-blinded, counterbalanced manner. After drug administration, participants performed a conversational reciprocity task by engaging in a short conversation with the researcher. Measurements of autonomic activity and anxiety were obtained before and after drug administration.

Results

Propranolol significantly improved performance on the conversational reciprocity task total [d = 0.40] and nonverbal communication domain scores when compared to the placebo condition. However, neither autonomic activity nor anxiety was significantly associated with drug response.

Conclusions

Acute propranolol administration improved conversational reciprocity in ASD. Further exploration of these preliminary findings, as well as other potential treatment response predictors, with serial doses is warranted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  • American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Press, Washington

    Google Scholar 

  • American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Press, Washington

    Google Scholar 

  • Bal E, Harden E, Lamb D, Van Hecke AV, Denver JW, Porges SW (2010) Emotion recognition in children with autism spectrum disorders: relations to eye gaze and autonomic state. J Autism Dev Disord 40:358–370

    Article  PubMed  Google Scholar 

  • Beck AT, Epstein N, Brown G, Steer RA (1988) An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 56:893–897

    Article  CAS  PubMed  Google Scholar 

  • Bellini S (2004) Social skill deficits and anxiety in high-functioning adolescents with autism spectrum disorders. Focus Autism Other Dev Stud 19:78–86

    Article  Google Scholar 

  • Berntson GG, Cacioppo JT, Quigley KS (1993) Respiratory sinus arrhythmia: autonomic origins, physiological mechanisms, and psychophysiological implications. Psychophysiology 30:183–196

    Article  CAS  PubMed  Google Scholar 

  • Beversdorf DQ, Carpenter AL, Miller RF, Cios JS, Hillier A (2008) Effect of propranolol on verbal problem solving in autism spectrum disorder. Neurocase 14:378–383

    Article  PubMed  Google Scholar 

  • Beversdorf DQ, Saklayen S, Higgins KF, Bodner KE, Kanne SM, Christ SE (2011) Effect of propranolol on word fluency in autism. Cogn Behav Neurol 24:11–17

    Article  PubMed  Google Scholar 

  • Bodner KE, Beversdorf DQ, Saklayen SS, Christ SE (2012) Noradrenergic moderation of working memory impairments in adults with autism spectrum disorder. J Int Neuropsychol Soc 18:556–564

    Article  PubMed  Google Scholar 

  • Charney DS, Redmond D (1983) Neurobiological mechanisms in human anxiety evidence supporting central noradrenergic hyperactivity. Neuropharmacology 22:1531–1536

    Article  CAS  PubMed  Google Scholar 

  • Cook EH, Leventhal BL, Heller W, Metz J, Wainwright M, Freedman DX (1990) Autistic children and their first-degree relatives: relationships between serotonin and norepinephrine levels and intelligence. J Neuropsychiatry Clin Neurosci 2:268–274

    Article  PubMed  Google Scholar 

  • Dadds M, MacDonald E, Cauchi A, Williams K, Levy F, Brennan J (2014) Nasal oxytocin for social deficits in childhood autism: a randomized controlled trial. J Autism Dev Disord 44:521–531

    Article  PubMed  Google Scholar 

  • Damasio AR (1996) The somatic marker hypothesis and the possible functions of the prefrontal cortex. Philos Trans R Soc Lond B Biol Sci 351:1413–1420

    Article  CAS  PubMed  Google Scholar 

  • Dawson ME, Schell AM, Filion DL (2007) The electrodermal system. In: Cacioppo JT, Tassinary LG, Berntson GG (eds) The handbook of psychophysiology, 3rd edn. Cambridge University Press, New York, pp 159–181

    Google Scholar 

  • Erickson C, Posey D, Stigler K, Mullett J, Katschke A, McDougle C (2007) A retrospective study of memantine in children and adolescents with pervasive developmental disorders. Psychopharmacology (Berl) 191:141–147

    Article  CAS  Google Scholar 

  • Erickson C, Veenstra-Vanderweele J, Melmed R, McCracken J, Ginsberg L, Sikich L et al (2014) STX209 (Arbaclofen) for autism spectrum disorders: an 8-week open-label study. J Autism Dev Disord 44:958–964

    Article  PubMed  Google Scholar 

  • Faigel HC (1991) The effect of beta blockade on stress-induced cognitive dysfunction in adolescents. Clin Pediatr 30:441–445

    Article  CAS  Google Scholar 

  • Farmer C, Thurm A, Grant P (2013) Pharmacotherapy for the core symptoms in autistic disorder: current status of the research. Drugs 73:303–314

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gaus V (2011) Adult Asperger syndrome and the utility of cognitive-behavioral therapy. J Contemp Psychother 41:47–56

    Article  Google Scholar 

  • Geschwind DH (2009) Advances in autism. Annu Rev Med 60:367–380

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gillott A, Furniss F, Walter A (2001) Anxiety in high-functioning children with autism. Autism 5:277–286

    Article  CAS  PubMed  Google Scholar 

  • Gillott A, Standen PJ (2007) Levels of anxiety and sources of stress in adults with autism. J Intellect Disabil 11:359–370

    Article  PubMed  Google Scholar 

  • Guy L, Souders M, Bradstreet L, DeLussey C, Herrington J (2014) Brief report: emotion regulation and respiratory sinus arrhythmia in autism spectrum disorder. J Autism Dev Disord 44:2614–2620

    Article  PubMed  Google Scholar 

  • Hasselmo ME, Linster C, Patil M, Ma D, Cekic M (1997) Noradrenergic suppression of synaptic transmission may influence cortical signal-to-noise ratio. J Neurophysiol 77:3326–3339

    CAS  PubMed  Google Scholar 

  • Hirstein W, Iversen P, Ramachandran VS (2001) Autonomic responses of autistic children to people and objects. Proc R Soc Lond B Biol 268:1883–1888

    Article  CAS  Google Scholar 

  • Heilman KJ, Bal E, Bazhenova OV, Sorokin Y, Perlman SB, Hanley MC et al (2008) Physiological responses to social and physical challenges in children: quantifying mechanisms supporting social engagement and mobilization behaviors. Dev Psychobiol 50:171–182

    Article  PubMed  Google Scholar 

  • Hollander E, Bartz J, Chaplin W, Phillips A, Sumner J, Soorya L et al (2007) Oxytocin increases retention of social cognition in autism. Biol Psychiatry 61:498–503

    Article  CAS  PubMed  Google Scholar 

  • Judd CM, Kenny DA, McClelland GH (2001) Estimating and testing mediation and moderation in within-subjects designs. Psychol Methods 6:115–134

    Article  CAS  PubMed  Google Scholar 

  • Kerns CM, Maddox BB, Kendall PC, Rump K, Berry L, Schultz RT et al (2015) Brief measures of anxiety in non-treatment-seeking youth with autism spectrum disorder. Autism 19(8):969–979. doi:10.1177/1362361314558465

    Article  PubMed  Google Scholar 

  • Lader M (1988) β-adrenoceptor antagonists in neuropsychiatry: an update. J Clin Psychiatry 49:213–223

    CAS  PubMed  Google Scholar 

  • Lake C, Ziegler MG, Murphy DL (1977) Increased norepinephrine levels and decreased dopamine-β-hydroxylase activity in primary autism. Arch Gen Psychiatry 34:553–556

    Article  CAS  PubMed  Google Scholar 

  • Launay J, Bursztejn C, Ferrari P, Dreux C, Braconnier A, Zarifian E et al (1987) Catecholamines metabolism in infantile autism: a controlled study of 22 autistic children. J Autism Dev Disord 17:333–347

    Article  CAS  PubMed  Google Scholar 

  • Lewis GF, Furman SA, McCool MF, Porges SW (2012) Statistical strategies to quantify respiratory sinus arrhythmia: are commonly used metrics equivalent? Biol Psychol 89:349–364

    Article  PubMed  PubMed Central  Google Scholar 

  • Lord C, Rutter M, Couteur A (1994) Autism diagnostic interview-revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 24:659–685

    Article  CAS  PubMed  Google Scholar 

  • Minderaa RB, Anderson GM, Volkmar FR, Akkerhuis GW, Cohen DJ (1994) Noradrenergic and adrenergic functioning in autism. Biol Psychiatry 36:237–241

    Article  CAS  PubMed  Google Scholar 

  • Ming X, Julu PO, Brimacombe M, Connor S, Daniels ML (2005) Reduced cardiac parasympathetic activity in children with autism. Brain Dev 27:509–516

    Article  PubMed  Google Scholar 

  • Montoya AK, Hayes AF (2015) Two condition within-participant statistical mediation analysis: a path-analytic framework., Under review

    Google Scholar 

  • Myers SM, Johnson CP (2007) Management of children with autism spectrum disorders. Pediatrics 120:1162–1182

    Article  PubMed  Google Scholar 

  • Narayanan A, White C, Saklayen S, Scaduto M, Carpenter A, Abduljalil A et al (2010) Effect of propranolol on functional connectivity in autism spectrum disorder: a pilot study. Brain Imaging Behav 4:189–197

    Article  PubMed  PubMed Central  Google Scholar 

  • Neuhaus E, Bernier R, Beauchaine T (2014) Brief report: social skills, internalizing and externalizing symptoms, and respiratory sinus arrhythmia in autism. J Autism Dev Disord 44:730–737

    Article  PubMed  Google Scholar 

  • Patriquin MA, Scarpa A, Friedman BH, Porges SW (2013) Respiratory sinus arrhythmia: a marker for positive social functioning and receptive language skills in children with autism spectrum disorders. Dev Psychobiol 55:101–112

    Article  PubMed  Google Scholar 

  • Pitzalis MV, Mastropasqua F, Massari F, Passantino A, Totaro P, Forleo C et al (1998) β-blocker effects on respiratory sinus arrhythmia and baroreflex gain in normal subjects. Chest 114:185–191

    Article  CAS  PubMed  Google Scholar 

  • Porges SW (1985) Method and apparatus for evaluating rhythmic oscillations in aperiodic physiological response systems. Patent Number: 4,510,944. U.S. Patent Office, Washington

    Google Scholar 

  • Porges SW (1995) Cardiac vagal tone: a physiological index of stress. Neurosci Biobehav Rev 19:225–233

    Article  CAS  PubMed  Google Scholar 

  • Porges SW (2005) The vagus: a mediator of behavioral and physiologic features. In: Bauman ML, Kemper TL (eds) The neurobiology of autism, 2nd edn. The Johns Hopkins University Press, Baltimore, pp 65–78

    Google Scholar 

  • Porges SW (2007) The polyvagal perspective. Biol Psychol 74:116–143

    Article  PubMed  PubMed Central  Google Scholar 

  • Porges SW, Bohrer RE (1990) Analyses of periodic processes in psychophysiological research. In: Cacioppo JT, Tassinary LG (eds) Principles of psychophysiology: physical, social, and inferential elements. Cambridge University Press, New York, pp 708–753

    Google Scholar 

  • Ratey JJ, Bemporad J, Sorgi P, Bick P, Polakoff S, O’Driscoll G et al (1987) Brief report: open trial effects of beta-blockers on speech and social behaviors in 8 autistic adults. J Autism Dev Disord 17:439–446

    Article  CAS  PubMed  Google Scholar 

  • Schaaf RC, Benevides TW, Leiby BE, Sendecki JA (2013) Autonomic dysregulation during sensory stimulation in children with autism spectrum disorder. J Autism Dev Disord 45:461–472

    Article  Google Scholar 

  • Spence SH (1998) A measure of anxiety symptoms among children. Behav Res Ther 36:545–566

    Article  CAS  PubMed  Google Scholar 

  • Stichter JP, Herzog MJ, O’Connor KV, Schmidt C (2012) A preliminary examination of a general social outcome measure. Assess Eff Interv 38:40–52

    Article  Google Scholar 

  • Tordjman S, McBride PA, Hertzig ME, Snow ME, Anderson GM, Hall LM et al (1997) Plasma β-endorphin, adrenocorticotropin hormone, and cortisol in autism. J Child Psychol Psychiatry 38:705–715

    Article  CAS  PubMed  Google Scholar 

  • Volkmar FR (2001) Pharmacological interventions in autism: theoretical and practical issues. J Clin Child Adolesc 30:80–87

    Article  CAS  Google Scholar 

  • Ward MM, Mefford IN, Parker SD, Chesney MA, Taylor CB, Keegan DL et al (1983) Epinephrine and norepinephrine responses in continuously collected human plasma to a series of stressors. Psychosom Med 45:471–486

    Article  CAS  PubMed  Google Scholar 

  • Wechsler D (1999) Wechsler abbreviated scale of intelligence. The Psychological Coorporation, San Antonio

    Google Scholar 

  • Young NJ, Findling RL (2015) An update on pharmacotherapy for autism spectrum disorder in children and adolescents. Curr Opin Psychiatry 28:91–101

    Google Scholar 

  • Zamzow RM, Christ SE, Saklayen SS, Moffitt AJ, Bodner KE, Higgins KF et al (2014) Effect of propranolol on facial scanning in autism spectrum disorder: a preliminary investigation. J Clin Exp Neuropsychol 36:431–445

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The study was supported by a grant from the Health Resources and Services Administration (1R40MC19926). We thank our many research assistants for their help with data collection and Nicole Takahashi and Jill Akers at the University of Missouri Thompson Center for Autism and Neurodevelopmental Disorders for their assistance with recruitment. We are grateful to all participants and their families who participated in this study. The experiments presented in this manuscript comply with the current US laws. This study was supported in part by the Center for Cognitive Aging and Memory at the University of Florida, the McKnight Brain Research Foundation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David Q. Beversdorf.

Ethics declarations

Conflict of interest

All authors declare no conflict of interest related to the present study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zamzow, R.M., Ferguson, B.J., Stichter, J.P. et al. Effects of propranolol on conversational reciprocity in autism spectrum disorder: a pilot, double-blind, single-dose psychopharmacological challenge study. Psychopharmacology 233, 1171–1178 (2016). https://doi.org/10.1007/s00213-015-4199-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-015-4199-0

Keywords

Navigation